Riondato Fulvio, Miniscalco Barbara, Poggi Alessia, Aricò Arianna, Aresu Luca, Comazzi Stefano, Martini Valeria
Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy.
Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, Padua, Italy.
Cytometry B Clin Cytom. 2016 Nov;90(6):525-530. doi: 10.1002/cyto.b.21353. Epub 2016 Feb 3.
Lymph node (LN), peripheral blood (PB), and bone marrow (BM) samples are commonly analyzed by flow cytometry (FC) for the immunophenotyping and staging of canine lymphomas. A prognostic value for FC BM infiltration in dogs with large B-cell lymphoma (LBCL) was demonstrated. Aim of this study was to define the analytical performances of this technique, and to establish a cutoff suitable to safely discriminate between infiltrated and noninfiltrated PB and BM samples.
Large B-cells were added to control PB and BM samples, to achieve twelve different large B-cells concentrations, ranging from 0 to 50%. The percentage of large B-cells was recorded for each dilution, using a BD Accuri C6 FC. Accuracy was evaluated by Passing-Bablok regression analysis. Intra-assay precision was assessed at 0%, 1, 3, and 10% dilutions evaluating the CVs of 10 repeated acquisitions. ROC curves were drawn to identify the cutoffs most suitable to discriminate between 25 infiltrated (PARR-positive) and 25 noninfiltrated (PARR-negative) PB and BM samples, respectively.
Optimal analytical accuracy and precision were achieved. Almost all CVs were <10%. Negative controls had up to 0.5% large B-cells, with 50 and 22% CV in PB and BM samples, respectively, 0.56 and 2.45% cutoffs were selected based on the ROC curves for PB and BM samples, respectively.
Quantification of large B-cells in PB and BM samples by FC is reliable and analytical performances met the acceptance criteria. Assessment of performances of different instruments and protocols is warranted. © 2016 International Clinical Cytometry Society.
淋巴结(LN)、外周血(PB)和骨髓(BM)样本通常通过流式细胞术(FC)进行分析,以用于犬淋巴瘤的免疫表型分析和分期。已证明FC骨髓浸润对大B细胞淋巴瘤(LBCL)犬具有预后价值。本研究的目的是确定该技术的分析性能,并建立一个合适的临界值,以安全地区分浸润和未浸润的PB和BM样本。
将大B细胞添加到对照PB和BM样本中,以达到12种不同的大B细胞浓度,范围从0%到50%。使用BD Accuri C6 FC记录每种稀释度下大B细胞的百分比。通过Passing-Bablok回归分析评估准确性。在0%、1%、3%和10%的稀释度下评估批内精密度,评估10次重复采集的变异系数(CV)。绘制ROC曲线以确定最适合分别区分25个浸润(PARR阳性)和25个未浸润(PARR阴性)PB和BM样本的临界值。
实现了最佳的分析准确性和精密度。几乎所有CV均<10%。阴性对照的大B细胞含量高达0.5%,PB和BM样本中的CV分别为50%和22%,根据ROC曲线分别为PB和BM样本选择的临界值为0.56%和2.45%。
通过FC对PB和BM样本中的大B细胞进行定量是可靠的,分析性能符合验收标准。有必要评估不同仪器和方案的性能。© 2016国际临床细胞计量学会。